About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline

H.R. 4299, Improving Regulatory Transparency for New Medical Therapies Act 1 (June 26, 2014)

handle is hein.congrec/cbo1727 and id is 1 raw text is: CONGRESSIONAL BUDGET OFFICE
COST ESTIMATE
June 26, 2014
H.R. 4299
Improving Regulatory Transparency for New Medical Therapies Act
As ordered reported by the House Committee on Energy and Commerce
on June 10, 2014
H.R. 4299 would modify the administrative procedures followed by the Department of
Justice in regulating new drugs that are already approved by the Food and Drug
Administration and in authorizing drugs to be used in clinical trials. The legislation would
aim to streamline the current review and approval process. CBO estimates that
implementing the bill would have no significant costs to the federal government. Enacting
the legislation would not affect direct spending or revenues; therefore, pay-as-you-go
procedures do not apply.
H.R. 4299 contains no intergovernmental or private-sector mandates as defined in the
Unfunded Mandates Reform Act and would impose no costs on state, local, or tribal
governments.
The CBO staff contact for this estimate is Mark Grabowicz. The estimate was approved by
Theresa Gullo, Deputy Assistant Director for Budget Analysis.

What Is HeinOnline?

HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.



Short-term subscription options include 24 hours, 48 hours, or 1 week to HeinOnline.

Contact us for annual subscription options:

Already a HeinOnline Subscriber?

profiles profiles most